TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
XBIT

XBiotech Inc

Healthcare · Biotechnology

2.20$ +0.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow XBIT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – -121.3% – – –
– +5.3% -0.1% +112.6% +63.9% -3.0% -5.2% +18.3% -1.3% -33.3% +0.1% -3.4%
– -37.2% +26.5% -68.6% -5.1% +102.3% +274.7% -64.5% +13.4% -35.6% -46.3% +106.6%
– -39.5% +31.1% -68.6% -5.1% +75.5% +328.7% -64.3% +76.2% – – –
– -133.1% – -970.3% – -3,568.1% – – -90.5% -64.2% -153.7% –
– +643.9% +33.9% -89.9% -91.3% +67.2% +1,727.0% -5.4% -83.4% -38.1% +260.2% -77.8%
– +643.9% +33.9% -89.9% -91.3% – -100.6% -5.4% +1,712.5% – -102.1% -77.8%
– – – – – +0.0% +0.0% +0.0% -100.0% – – –
– +21.3% -96.2% +1,031.9% -99.4% +20,693.0% -1,104.9% – – – – –
– +0.0% – – – – – – – – – -200.0%
– +22.6% -96.2% +1,031.9% -99.4% +20,843.3% -1,073.3% -83.6% – -127.3% – -198.1%
– -32.7% -268.2% – – – -168.3% – – – -164.0% –
– – – – – – – – -123.4% – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?